205 related articles for article (PubMed ID: 31763975)
41. Synthesis, antimicrobial and cytotoxic activities, and molecular docking studies of N-arylsulfonylindoles containing an aminoguanidine, a semicarbazide, and a thiosemicarbazide moiety.
Song M; Wang S; Wang Z; Fu Z; Zhou S; Cheng H; Liang Z; Deng X
Eur J Med Chem; 2019 Mar; 166():108-118. PubMed ID: 30685534
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of beta-ketoacyl-acyl carrier protein synthase III (FabH) by acyl-acyl carrier protein in Escherichia coli.
Heath RJ; Rock CO
J Biol Chem; 1996 May; 271(18):10996-1000. PubMed ID: 8631920
[TBL] [Abstract][Full Text] [Related]
43. Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.
Nie Z; Perretta C; Lu J; Su Y; Margosiak S; Gajiwala KS; Cortez J; Nikulin V; Yager KM; Appelt K; Chu S
J Med Chem; 2005 Mar; 48(5):1596-609. PubMed ID: 15743201
[TBL] [Abstract][Full Text] [Related]
44. Substrate recognition by β-ketoacyl-ACP synthases.
Borgaro JG; Chang A; Machutta CA; Zhang X; Tonge PJ
Biochemistry; 2011 Dec; 50(49):10678-86. PubMed ID: 22017312
[TBL] [Abstract][Full Text] [Related]
45. Homology modeling and docking studies of FabH (β-ketoacyl-ACP synthase III) enzyme involved in type II fatty acid biosynthesis of Chlorella variabilis: a potential algal feedstock for biofuel production.
Misra N; Patra MC; Panda PK; Sukla LB; Mishra BK
J Biomol Struct Dyn; 2013 Mar; 31(3):241-57. PubMed ID: 22830394
[TBL] [Abstract][Full Text] [Related]
46. A combined approach of docking and 3D QSAR study of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Ashek A; Cho SJ
Bioorg Med Chem; 2006 Mar; 14(5):1474-82. PubMed ID: 16275103
[TBL] [Abstract][Full Text] [Related]
47. Docking studies of flavonoid compounds as inhibitors of β-ketoacyl acyl carrier protein synthase I (Kas I) of Escherichia coli.
Sabbagh G; Berakdar N
J Mol Graph Model; 2015 Sep; 61():214-23. PubMed ID: 26292066
[TBL] [Abstract][Full Text] [Related]
48. Structural Characterisation of the Beta-Ketoacyl-Acyl Carrier Protein Synthases, FabF and FabH, of Yersinia pestis.
Nanson JD; Himiari Z; Swarbrick CM; Forwood JK
Sci Rep; 2015 Oct; 5():14797. PubMed ID: 26469877
[TBL] [Abstract][Full Text] [Related]
49. Discovery and modification of sulfur-containing heterocyclic pyrazoline derivatives as potential novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Yang YS; Zhang F; Gao C; Zhang YB; Wang XL; Tang JF; Sun J; Gong HB; Zhu HL
Bioorg Med Chem Lett; 2012 Jul; 22(14):4619-24. PubMed ID: 22721711
[TBL] [Abstract][Full Text] [Related]
50. Structural evidence for the covalent modification of FabH by 4,5-dichloro-1,2-dithiol-3-one (HR45).
Ekström AG; Kelly V; Marles-Wright J; Cockroft SL; Campopiano DJ
Org Biomol Chem; 2017 Aug; 15(30):6310-6313. PubMed ID: 28715001
[TBL] [Abstract][Full Text] [Related]
51. PqsBC, a Condensing Enzyme in the Biosynthesis of the Pseudomonas aeruginosa Quinolone Signal: CRYSTAL STRUCTURE, INHIBITION, AND REACTION MECHANISM.
Drees SL; Li C; Prasetya F; Saleem M; Dreveny I; Williams P; Hennecke U; Emsley J; Fetzner S
J Biol Chem; 2016 Mar; 291(13):6610-24. PubMed ID: 26811339
[TBL] [Abstract][Full Text] [Related]
52. Gating mechanism of elongating β-ketoacyl-ACP synthases.
Mindrebo JT; Patel A; Kim WE; Davis TD; Chen A; Bartholow TG; La Clair JJ; McCammon JA; Noel JP; Burkart MD
Nat Commun; 2020 Apr; 11(1):1727. PubMed ID: 32265440
[TBL] [Abstract][Full Text] [Related]
53. Development of a scintillation proximity assay for beta-ketoacyl-acyl carrier protein synthase III.
He X; Mueller JP; Reynolds KA
Anal Biochem; 2000 Jun; 282(1):107-14. PubMed ID: 10860506
[TBL] [Abstract][Full Text] [Related]
54. QSAR studies on benzoylaminobenzoic acid derivatives as inhibitors of beta-ketoacyl-acyl carrier protein synthase III.
Singh S; Soni LK; Gupta MK; Prabhakar YS; Kaskhedikar SG
Eur J Med Chem; 2008 May; 43(5):1071-80. PubMed ID: 17707951
[TBL] [Abstract][Full Text] [Related]
55. Bacterial β-ketoacyl-acyl carrier protein synthase III (FabH) as a target for novel antibacterial agents design.
Lu XY; Tang J; Zhang Z; Ding K
Curr Med Chem; 2015; 22(5):651-67. PubMed ID: 25515508
[TBL] [Abstract][Full Text] [Related]
56. Bacterial beta-ketoacyl-acyl carrier protein synthase III (FabH): an attractive target for the design of new broad-spectrum antimicrobial agents.
Castillo YP; Pérez MA
Mini Rev Med Chem; 2008 Jan; 8(1):36-45. PubMed ID: 18220983
[TBL] [Abstract][Full Text] [Related]
57. Characterization of beta-ketoacyl-acyl carrier protein synthase III from Streptomyces glaucescens and its role in initiation of fatty acid biosynthesis.
Han L; Lobo S; Reynolds KA
J Bacteriol; 1998 Sep; 180(17):4481-6. PubMed ID: 9721286
[TBL] [Abstract][Full Text] [Related]
58. Novel E. coli beta-ketoacyl-acyl carrier protein synthase III inhibitors as targeted antibiotics.
Lee JY; Jeong KW; Lee JU; Kang DI; Kim Y
Bioorg Med Chem; 2009 Feb; 17(4):1506-13. PubMed ID: 19185501
[TBL] [Abstract][Full Text] [Related]
59. Isolation and structure of platencin: a FabH and FabF dual inhibitor with potent broad-spectrum antibiotic activity.
Jayasuriya H; Herath KB; Zhang C; Zink DL; Basilio A; Genilloud O; Diez MT; Vicente F; Gonzalez I; Salazar O; Pelaez F; Cummings R; Ha S; Wang J; Singh SB
Angew Chem Int Ed Engl; 2007; 46(25):4684-8. PubMed ID: 17487925
[No Abstract] [Full Text] [Related]
60. Discovery of novel selective inhibitors of Staphylococcus aureus β-ketoacyl acyl carrier protein synthase III.
Lee JY; Jeong KW; Shin S; Lee JU; Kim Y
Eur J Med Chem; 2012 Jan; 47(1):261-9. PubMed ID: 22104972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
